What does ALPHABIOTOXINE LABORATORY do?

ALPHABIOTOXINE LABORATORY is a research organisation in Frasnes-lez-Anvaing. Private Limited, started on 20 May 2016, 1 establishment.

What is the address of ALPHABIOTOXINE LABORATORY?

The registered office of ALPHABIOTOXINE LABORATORY is located at Barberie(MB) 15, 7911 Frasnes-lez-Anvaing.

Is ALPHABIOTOXINE LABORATORY still active?

Yes. According to the CBE (30 October 2026) ALPHABIOTOXINE LABORATORY is active, legal situation “Normale toestand”, started on 20 May 2016.

Is ALPHABIOTOXINE LABORATORY registered on Peppol?

Yes, ALPHABIOTOXINE LABORATORY is registered on the Peppol network with ID 0208:0654859074.

What is the enterprise number of ALPHABIOTOXINE LABORATORY?

The enterprise number of ALPHABIOTOXINE LABORATORY is BE0654859074.

When was ALPHABIOTOXINE LABORATORY founded?

ALPHABIOTOXINE LABORATORY was founded on 20 May 2016.

Who are the directors of ALPHABIOTOXINE LABORATORY?

According to the 2025 annual accounts, the directors of ALPHABIOTOXINE LABORATORY are: Aude VIOLETTE.

Is ALPHABIOTOXINE LABORATORY a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 20 May 2016; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did ALPHABIOTOXINE LABORATORY make in 2025?

ALPHABIOTOXINE LABORATORY posted a profit after taxes of € 854 in financial year 2025.

What is the revenue of ALPHABIOTOXINE LABORATORY?

As a small company, ALPHABIOTOXINE LABORATORY is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 7,429.

ALPHABIOTOXINE LABORATORY (Private Limited)

Dossier ALPHABIOTOXINE LABORATORY, printed on 30 October 2026 from databakkes.be/en/0654859074/alphabiotoxine-laboratory. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 61 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

ALPHABIOTOXINE LABORATORY from Frasnes-lez-Anvaing, company number BE0654859074, closed financial year 2025 with a result of € 854 after tax. For that financial year ALPHABIOTOXINE LABORATORY recorded a gross margin of € 7,429 and equity of € 589. Compared with financial year 2024, the result moved from € 6,737 to € 854. The company is profitable. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on August 11, 2026.

What it is worth Growing

€ 589

▲ € 854 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 854

▼ 87% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 64,165

▲ 7% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € -18,011.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 703

▼ 58% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,536

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,634

▼ 46% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -19,028 Gross margin 2022: € -19,028 First fiscal year in the series	€ 60,268 Gross margin 2023: € 60,268 ▲ € 79,296 vs 2022 (€ -19,028) Favourable step	€ 13,371 Gross margin 2024: € 13,371 ▼ 78% vs 2023 (€ 60,268) Unfavourable step	€ 7,429 Gross margin 2025: € 7,429 ▼ 44% vs 2024 (€ 13,371) Unfavourable step	▼ 44%
Profit after taxes	€ -27,919 Profit after taxes 2022: € -27,919 First fiscal year in the series	€ 48,884 Profit after taxes 2023: € 48,884 ▲ € 76,803 vs 2022 (€ -27,919) Favourable step	€ 6,737 Profit after taxes 2024: € 6,737 ▼ 86% vs 2023 (€ 48,884) Unfavourable step	€ 854 Profit after taxes 2025: € 854 ▼ 87% vs 2024 (€ 6,737) Unfavourable step	▼ 87%
Equity	€ -55,886 Equity 2022: € -55,886 First fiscal year in the series	€ -7,002 Equity 2023: € -7,002 ▲ € 48,884 vs 2022 (€ -55,886) Favourable step	€ -265 Equity 2024: € -265 ▲ € 6,737 vs 2023 (€ -7,002) Favourable step	€ 589 Equity 2025: € 589 ▲ € 854 vs 2024 (€ -265) Favourable step	▲ € 854
Total debts	€ 126,290 Total debts 2022: € 126,290 First fiscal year in the series	€ 122,858 Total debts 2023: € 122,858 ▼ 3% vs 2022 (€ 126,290) Favourable step	€ 109,119 Total debts 2024: € 109,119 ▼ 11% vs 2023 (€ 122,858) Favourable step	€ 110,150 Total debts 2025: € 110,150 ▲ 1% vs 2024 (€ 109,119) Unfavourable step	▲ 1%
Cash	€ 26,113 Cash 2022: € 26,113 First fiscal year in the series	€ 72,963 Cash 2023: € 72,963 ▲ 179% vs 2022 (€ 26,113) Favourable step	€ 59,921 Cash 2024: € 59,921 ▼ 18% vs 2023 (€ 72,963) Unfavourable step	€ 64,165 Cash 2025: € 64,165 ▲ 7% vs 2024 (€ 59,921) Favourable step	▲ 7%
Land & buildings	€ 5,457 Land & buildings 2022: € 5,457 First fiscal year in the series	€ 5,680 Land & buildings 2023: € 5,680 ▲ 4% vs 2022 (€ 5,457) Unchanged	€ 4,756 Land & buildings 2024: € 4,756 ▼ 16% vs 2023 (€ 5,680) Unchanged	€ 3,956 Land & buildings 2025: € 3,956 ▼ 17% vs 2024 (€ 4,756) Unchanged	▼ 17%
Retained profit	€ -74,486 Retained profit 2022: € -74,486 First fiscal year in the series	€ -25,602 Retained profit 2023: € -25,602 ▲ € 48,884 vs 2022 (€ -74,486) Favourable step	€ -18,865 Retained profit 2024: € -18,865 ▲ € 6,737 vs 2023 (€ -25,602) Favourable step	€ -18,011 Retained profit 2025: € -18,011 ▲ € 854 vs 2024 (€ -18,865) Favourable step	▲ € 854
Balance sheet total	€ 70,404 Balance sheet total 2022: € 70,404 First fiscal year in the series	€ 115,856 Balance sheet total 2023: € 115,856 ▲ 65% vs 2022 (€ 70,404) Unchanged	€ 108,854 Balance sheet total 2024: € 108,854 ▼ 6% vs 2023 (€ 115,856) Unchanged	€ 110,739 Balance sheet total 2025: € 110,739 ▲ 2% vs 2024 (€ 108,854) Unchanged	▲ 2%

Key figures of ALPHABIOTOXINE LABORATORY, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ALPHABIOTOXINE LABORATORY?

What happened at ALPHABIOTOXINE LABORATORY in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 11, 2026 New annual accounts for financial year 2025: profit of € 854 (▼ 87% vs 2024). filed late Source: NBB ↗
May 20, 2016 New establishment in Frasnes-lez-Anvaing. KBO
May 20, 2016 Start of the company according to the CBE. KBO

In short

From € 27,919 loss in 2022 to € 854 profit in 2025.

Paid € 908 in corporate taxes since 2022.

Best year ever: 2023, with € 48,884 profit.

Original PDFs at the National Bank ↗

Management

Aude VIOLETTE

ALPHABIOTOXINE LABORATORY

Behind ALPHABIOTOXINE LABORATORY is Aude VIOLETTE.

Directors

According to the 2025 annual accounts

Aude VIOLETTE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Barberie(MB) 15

7911 Frasnes-lez-Anvaing

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0654.859.074

VAT number

BE 0654.859.074

Registered office

Barberie(MB) 15, 7911 Frasnes-lez-Anvaing

Names & denominations

ALPHABIOTOXINE LABORATORY

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

20 May 2016

Peppol

Active · Active since 3 Dec 2025

Activities · NACE

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Handelsbemiddeling in de groothandel in andere specifieke goederen

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Overige zakelijke dienstverlening, neg

Overige gespecialiseerde wetenschappelijke en technische activiteiten

View on CBE Public ↗ Annual accounts (NBB) ↗

ALPHABIOTOXINE LABORATORY

Warning lights

Financials

What happened to ALPHABIOTOXINE LABORATORY?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions